Casias v. Wal-Mart Stores, Inc.
A 2012 federal appeal ruling on medical cannabis patients' employment rights.
This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.
Casias is often cited to mean 'employers can always fire you for testing positive.' That's roughly true in Michigan and the Sixth Circuit, but it's not the whole story. The ruling turned on how the 2008 Michigan statute was written—it simply didn't address employment. Dozens of states have since passed laws that explicitly protect patients. If you live elsewhere, your statute may say something different. Always check your own state's law.
Background
Joseph Casias was an inventory control manager at a Wal-Mart in Battle Creek, Michigan. He had been diagnosed with sinus cancer and an inoperable brain tumor as a teenager and lived with chronic pain [1]. After Michigan voters passed the Michigan Medical Marihuana Act (MMMA) in 2008, Casias obtained a registry card and began using cannabis on the recommendation of his oncologist [1].
In November 2009, Casias twisted his knee at work and was sent for a drug test under Wal-Mart's standard post-injury policy. He disclosed his MMMA registry card to the testing clinic and informed his manager. The test came back positive for THC metabolites, and Wal-Mart terminated him for violating its drug-use policy [2].
Procedural history
Casias, represented by the ACLU of Michigan, sued Wal-Mart in Michigan state court in 2010, alleging wrongful discharge in violation of Michigan public policy and a direct violation of the MMMA's protections under MCL 333.26424(a).
Wal-Mart removed the case to federal court (U.S. District Court for the Western District of Michigan) on diversity grounds. In February 2011, Judge Robert Jonker granted Wal-Mart's motion to dismiss, holding that the MMMA does not regulate private employment and does not create a private cause of action against private employers [2].
Casias appealed to the Sixth Circuit. On September 19, 2012, a three-judge panel affirmed the dismissal [1].
The Sixth Circuit's reasoning
The central interpretive question was how to read MCL 333.26424(a), which states that a qualifying patient "shall not be subject to arrest, prosecution, or penalty in any manner, or denied any right or privilege, including but not limited to civil penalty or disciplinary action by a business or occupational or professional licensing board or bureau" for medical use in compliance with the Act Strong evidence[1][4].
Casias argued that "penalty in any manner" and the word "business" encompassed private employers like Wal-Mart. The Sixth Circuit rejected that interpretation for several reasons [1]:
Textual context. The court read the phrase "business or occupational or professional licensing board or bureau" as a single construction in which "business" modifies licensing bodies, not as referring to stand-alone private businesses. The listed entities—licensing boards and bureaus—are governmental in character.
Absence of an employment provision. The MMMA, unlike many later state statutes, contains no explicit language protecting employees from adverse employment action or prohibiting employer discrimination based on cardholder status.
No implied private right of action. Michigan follows a restrictive test for implying private rights of action. Nothing in the MMMA's text or structure indicated that voters intended to create one against private employers.
Public policy claim fails. Because the MMMA itself did not create employment protections, it could not serve as the basis for a common-law wrongful-discharge claim grounded in public policy.
The panel emphasized it was not deciding whether cannabis use is sound policy, only what the statute as written actually provides [1].
What the ruling did and did not decide
What Casias decided: Under the MMMA as written in 2012, a private Michigan employer could lawfully terminate a registered medical cannabis patient for a positive drug test without violating the Act or Michigan common law Strong evidence[1].
What it did not decide:
- Federal drug-testing requirements (e.g., Federal Employment Drug Testing Rules or Department of Transportation regulations for safety-sensitive positions).
- Disability discrimination claims under the Americans with Disabilities Act or Michigan disability statutes.
- State laws enacted after 2012 that explicitly protect medical cannabis patients in employment.
- Cases outside the Sixth Circuit; the ruling is binding only in Michigan, Ohio, Kentucky, and Tennessee, though courts elsewhere may cite it as persuasive authority for interpreting similarly worded statutes.
Notably, the decision does not address whether THC metabolites—which can remain detectable for weeks after use—are equivalent to evidence of impairment on the job. That distinction became important in later state employment-protection statutes.
Evolution of state law since 2012
The MMMA was among the first generation of state medical cannabis laws. These statutes were largely silent on employment. A second wave of statutes, enacted from roughly 2015 onward, explicitly addressed employment protections.
Examples of states with employment protections include Strong evidence:
- Arizona (Ariz. Rev. Stat. § 36-2813(B)): prohibits discrimination against registered patients unless the employer would lose a federal benefit or contract [4].
- Connecticut (Conn. Gen. Stat. § 21a-408p(b)(3)): bars employers from refusing to hire or terminating solely because someone is a qualifying patient.
- New York, New Jersey, Pennsylvania, Delaware, Minnesota, Nevada, Oklahoma, and Rhode Island have enacted various employment-protection provisions.
Courts applying these newer statutes have frequently rejected the reasoning in Casias. For example, in Noffsinger v. SSC Niantic Operating Co. (D. Conn. 2018), the Connecticut court allowed a medical cannabis employment discrimination claim to proceed [5]. Similarly, in Wild v. Carriage Funeral Holdings, Inc. (N.J. 2020), the New Jersey Supreme Court recognized employment protections for registered patients [6].
Michigan itself has not amended the MMMA to add explicit employment protections as of October 2026 Strong evidence. The state's 2018 recreational legalization initiative (the Marijuana Regulation and Taxation Act) also does not provide employment protections and expressly permits employers to maintain drug-testing policies [7]. Accordingly, Casias remains controlling Michigan authority on this narrow issue.
Practical implications
- A medical cannabis registry card does not guarantee employment protection. Whether you have legal recourse depends entirely on your state statute. Check the specific language of your state's medical cannabis law, particularly any section addressing employment or discrimination.
- Safety-sensitive and federally regulated roles are typically carved out. Even in states with employment protections, positions regulated by the Department of Transportation, safety-sensitive roles at federal contractors, and positions governed by Federal Employment Drug Testing Rules are often exempt.
- Drug tests detect metabolites, not impairment. Standard urinalysis detects THC-COOH, an inactive metabolite that can remain in the body for weeks. Whether the test result is legally relevant depends on the statute; many newer employment-protection laws distinguish between off-duty use and on-the-job impairment.
- State law varies widely. If you are a medical cannabis patient facing employment drug testing, read your state's statute before assuming protection. Look specifically for sections on "Employment," "Discrimination," or "Employer Rights."
This is not legal advice. Case law and statutes change, and circumstances vary. Consult a licensed attorney in your jurisdiction for advice specific to your situation.
Sources
- Reported Casias v. Wal-Mart Stores, Inc., 695 F.3d 428 (6th Cir. 2012).
- Reported Casias v. Wal-Mart Stores, Inc., 764 F. Supp. 2d 914 (W.D. Mich. 2011).
- Government Michigan Medical Marihuana Act, Initiated Law 1 of 2008, MCL 333.26421 et seq., § 4(a).
- Government Arizona Revised Statutes § 36-2813(B). Medical marijuana protections.
- Reported Noffsinger v. SSC Niantic Operating Co., 338 F. Supp. 3d 78 (D. Conn. 2018).
- Reported Wild v. Carriage Funeral Holdings, Inc., 241 N.J. 285 (2020).
- Government Michigan Regulation and Taxation of Marihuana Act, Initiated Law 1 of 2018, MCL 333.27954(3). Employer rights and drug policies.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Federal Cannabis Law in the United States — How federal prohibition coexists with state legalization, and what may change.
- Federal Employment Drug Testing Rules — Federal workplace drug testing rules, cannabis Schedule I status, and why state legalizati...